CN212281498U - Nasal cavity filler for hemostasis - Google Patents
Nasal cavity filler for hemostasis Download PDFInfo
- Publication number
- CN212281498U CN212281498U CN202022000813.4U CN202022000813U CN212281498U CN 212281498 U CN212281498 U CN 212281498U CN 202022000813 U CN202022000813 U CN 202022000813U CN 212281498 U CN212281498 U CN 212281498U
- Authority
- CN
- China
- Prior art keywords
- nasal cavity
- filler
- nasal
- filler body
- filling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Media Introduction/Drainage Providing Device (AREA)
Abstract
The utility model relates to the technical field of medical equipment, in particular to a nasal cavity filler for hemostasis. The nasal cavity filler comprises a filler body, wherein the filler body is an elastic piece which is reduced in proportion according to the shape of the nasal cavity; the filler body is capable of absorbing liquid expansion; after expansion, the filler body is an elastic piece which is enlarged in proportion to the shape of the nasal cavity. Through the filler body based on human nasal cavity structural morphology design, use elastic material, the cooperation inflation oppression, the filler body after the inflation can be abundant contact nasal cavity's four walls, and the depressed part of filler body corresponds each protruding position in the nose, can carry out whole or partial physical separation between structures such as well turbinate, inferior turbinate, nasal septum, maxillary frontal process, realizes the effect of antiseized.
Description
Technical Field
The utility model relates to the technical field of medical equipment, in particular to a nasal cavity filler for hemostasis.
Background
After the operation of nasal cavity and nasal sinus of the clinical otorhinolaryngology department, the operation part needs to be healed by a hemostasis means, the healing can not be carried out by an operation suture means due to the particularity of the nasal cavity operation, generally, the hemostasis is carried out by filling a nasal cavity filler and applying compression force, and the filler is taken out after the wound is healed.
At present, vaseline gauze and an expansion hemostatic sponge are commonly used in clinic to perform nasal cavity hemostasis. In the using process, the vaseline sliver is generally used for 5-10 minutes in the filling process, the filling is slow, great pain is caused to a patient in the filling process, and the patient cannot tolerate the vaseline sliver in different degrees after the vaseline sliver is filled. The expansion hemostasis sponge is mainly in the shape of a strip with various thicknesses, pressure is applied to hemostasis after expansion of absorbed liquid, the expansion hemostasis sponge is more friendly to clinical experience compared with vaseline yarn strips, but due to the fact that the structure of a human nasal cavity is irregular, contact is poor when the expansion hemostasis sponge is used for compressing positions of the nasal cavity, a paranasal sinus and the like, pressure at each position is uneven, and compression hemostasis and anti-adhesion effects need to be improved.
In conclusion, the existing nasal cavity filler for hemostasis has the problems of poor comfort and poor hemostasis effect in the using process.
SUMMERY OF THE UTILITY MODEL
The utility model aims to provide a: aiming at the problems of poor comfort and poor hemostatic effect of the existing hemostatic nasal cavity filler in the prior art, the hemostatic nasal cavity filler is provided.
In order to realize the purpose, the utility model discloses a technical scheme be:
a nasal cavity filler comprises a filler body,
the filler body is an elastic part which is reduced in proportion according to the shape of the nasal cavity;
the filler body is capable of absorbing liquid expansion;
after expansion, the filler body is an elastic piece which is enlarged in proportion to the shape of the nasal cavity.
Through the design based on human nasal cavity structure morphological characteristics with the filler body, the cooperation inflation oppression, arrange the less filler body of volume in the nasal cavity, the filler body is after absorbing liquid, after liquid includes water, normal saline or antibiotic solution, the volume is the proportional expansion, still be the structure similar with the nasal cavity structure, the filler body after the inflation can be abundant contact the four walls of nasal cavity, each protruding position in the nose is corresponded to the depressed part of filler body, can carry out whole or partial physical separation between structures such as well turbinate, inferior turbinate, nasal septum, maxillary frontal process, realize antiseized effect.
As a preferable scheme of the utility model, a plurality of ventilation channels are arranged on the filler body;
when the filler body is placed in the nasal cavity, one end of the ventilation passage is communicated with the outer side of the nasal cavity, and the other end of the ventilation passage is communicated with the inner side of the nasal cavity.
The ventilation channel is a ventilation pipe penetrating through the filler body or a groove arranged on the four walls of the filler body. Preferably, the vent passage is a straight vent tube extending through the filler body.
The ventilation effect of the filler is improved by arranging the ventilation passage. Reducing the discomfort of the patient.
As a preferred scheme of the utility model, the filler body comprises at least one of an upper nasal meatus filling component, a middle nasal meatus filling component and a lower nasal meatus filling component;
the upper nasal passage filling assembly is matched with the upper nasal passage of the nasal cavity; the middle nasal passage filling assembly is matched with the middle nasal passage of the nasal cavity; the inferior meatus filling component is matched with the inferior meatus of the nasal cavity.
By dividing the filler body into three different filling assemblies, the filling assembly of the corresponding part is selected for patients of different operations. The portion not requiring hemostasis is not provided with a filling assembly. Can be more flexibly suitable for patients with different operation types. The ventilation effect is improved.
As a preferred aspect of the present invention, the upper nasal meatus filling assembly includes a first recessed portion; the middle nasal meatus filling assembly comprises a second concave part; the inferior meatus filling assembly includes a third depression.
The first concave part corresponds to the upper turbinate part, the second concave part corresponds to the middle turbinate part, and the third concave part corresponds to the lower turbinate part.
Among the three filling assemblies, all contained sunken parts, and corresponded nasal cavity turbinate structure respectively, can be solitary fix in the nasal cavity.
As the preferred proposal of the utility model, the filler body is of an integrated structure.
When two or three filling assemblies are needed, an integrated structure is adopted, the nasal cavity is conveniently placed into the nasal cavity, relative displacement among a plurality of assemblies is avoided, fixing of the filler in the nasal cavity is facilitated, and the hemostatic effect is favorably improved on the basis of good fixing.
As the preferred scheme of the utility model, the proportion of filler body and nasal cavity is 0.1 ~ 0.5: 1; after the liquid is absorbed and expanded, the ratio of the filler body to the nasal cavity is 1.2-1.5: 1.
When the filler body is in the proportion before expansion, the filler body can be conveniently placed into the nasal cavity, and the interval between the sunken part in the structure and the corresponding nasal cavity frontal process is smaller. When the filler body absorbs liquid expansion, the depressed part of the filler body can be quickly contacted with the frontal protruding part of the nasal cavity, and the nasal cavity frontal protruding part can play a limiting role in the depressed part, so that the filler body is prevented from shifting.
When the ratio is in the range, the filler body can generate enough pressure on the nasal cavity wall after expansion, thereby achieving good compression hemostasis effect. The ratio of the expanded filler to the expanded filler is 1.2 to 1.5:1, which is a ratio at which the filler body can expand to the maximum after absorbing water sufficiently without restriction of the nasal cavity. In the practical use process, the volume of the filler body is slightly larger than that of the nasal cavity under the limit of the nasal cavity, and pressure is formed on the nasal cavity wall.
As the preferred proposal of the utility model, a plurality of micropore structures are arranged in the filler body.
The microporous structure is arranged, so that the ventilation effect is improved; and the elasticity of the filler is increased, so that the filler is more stably contacted with the nasal cavity, and the hemostasis is facilitated. The microporous structure can also realize that antibacterial drugs are added into the microporous structure in a soaking or injection mode and the like, so that the antibacterial function of the filler is realized.
As the preferred proposal of the utility model, the micro-porous structure is internally provided with drugs.
The healing of the wound in the nasal cavity is promoted in a drug-loading mode.
As a preferable scheme of the utility model, the filler body can expand to the maximum volume within 2-10s after absorbing liquid.
The manufacturing method of the nasal cavity filler comprises the following steps,
s1, acquiring CT or MRI scanning data in the nasal cavity, and establishing a three-dimensional model of the nasal cavity;
s2, manufacturing a nasal cavity mold according to the three-dimensional model of the nasal cavity;
s3, filling the filling material subjected to foaming treatment into a nasal cavity mold, and molding;
s4, mechanically compressing the material formed in the step S3 to obtain the nasal cavity filler.
Preferably, in step S3, the filling material used is one or more of polyvinyl alcohol, chitosan, alginate, and gelatin.
Preferably, in step S3, the foaming process is to mix an auxiliary material with a filler; the auxiliary materials comprise a cross-linking agent, a foam stabilizer and a foaming agent.
The through ventilation pipe can be arranged in a physical penetration mode. Or a bulge is arranged on the nasal cavity mould, and a ventilation groove is formed corresponding to the outer side wall of the filler body.
By making a nasal cavity mold by using the set-up model, the filler in the shape of the nasal cavity is equalized to an equal ratio after molding at step S3, and has air bubbles and ventilation channels inside. Its own volume and structure are similar to those of a real nasal cavity. And a material capable of absorbing moisture and expanding is used, and the material can expand immediately after absorbing moisture. After the nasal cavity is compressed in a mechanical compression mode, the volume of the internal bubbles is reduced or disappears, the whole volume is reduced, and the nasal cavity can be conveniently placed in.
To sum up, owing to adopted above-mentioned technical scheme, the beneficial effects of the utility model are that:
1. the utility model discloses a nasal cavity filler, through the filler body based on human nasal cavity structural morphology design, use elastic material, cooperation inflation oppression, the filler body after the inflation can be abundant four walls of contact nasal cavity, and the depressed part of filler body corresponds each protruding position in the nose, can carry out whole or partial physics between well turbinate, inferior turbinate, nasal septum, maxillary frontal process isotructure and separate, realizes the effect of antiseized even.
2. The utility model discloses a nasal cavity filler through setting up air passage and microporous structure, has increased the air permeability of filler, and has increased the elasticity of filler, has promoted patient's travelling comfort.
3. The utility model discloses a nasal cavity filler through will be through being divided into three different filling assembly with the filler body, to the patient of different operations, selects the filling assembly that corresponds the position to and set up a plurality of parts integration that will select, on the basis that keeps the fixed effect of filler, can reduce unnecessary filling assembly, be favorable to promoting the ventilation effect.
Drawings
Fig. 1 is a schematic front view of the nasal cavity filler of the present invention.
Fig. 2 is a left side view structure diagram of the nasal cavity filler of the present invention.
Fig. 3 is a right side view structure diagram of the nasal cavity filler of the present invention.
Fig. 4 is a schematic view showing a front view of the nasal cavity filler of the present invention in use.
Fig. 5 is a left side view schematically illustrating the usage state of the nasal cavity filler of the present invention.
Icon: 1-an upper nasal meatus filling assembly; 2-middle meatus filling component; 3-inferior meatus filling component.
Detailed Description
The present invention will be described in detail with reference to the accompanying drawings.
In order to make the objects, technical solutions and advantages of the present invention more clearly understood, the present invention is further described in detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are for purposes of illustration only and are not intended to limit the invention.
Example 1
A nasal cavity filler comprises a filler body which is an elastic piece that is proportionally reduced according to the shape of a nasal cavity, as shown in figures 1-3; the filler body can expand when absorbing liquid; after expansion, the filler body is an elastic piece which is enlarged in proportion to the shape of the nasal cavity.
The filler body comprises at least one of an upper nasal meatus filling component 1, a middle nasal meatus filling component 2 and a lower nasal meatus filling component 3;
the upper nasal passage filling assembly 1 is matched with the upper nasal passage of the nasal cavity; the middle nasal passage filling assembly 2 is matched with the middle nasal passage of the nasal cavity; the inferior meatus filling component 3 is matched with the inferior meatus of the nasal cavity.
By dividing the filler body into three different filling assemblies, the filling assembly of the corresponding part is selected for patients of different operations. The portion not requiring hemostasis is not provided with a filling assembly. Can be more flexibly suitable for patients with different operation types. The ventilation effect is improved.
The upper meatus filling assembly comprises a first concave part; the middle nasal meatus filling assembly comprises a second concave part; the inferior meatus filling assembly includes a third depression.
The first concave part corresponds to the upper turbinate part, the second concave part corresponds to the middle turbinate part, and the third concave part corresponds to the lower turbinate part.
Among the three filling assemblies, all contained sunken parts, and corresponded nasal cavity turbinate structure respectively, can be solitary fix in the nasal cavity.
The filler body is provided with a plurality of vent pipes; the breather pipes penetrate through the filler body, one end of the breather pipe is communicated with the outer side of the nasal cavity, and the other end of the breather pipe is communicated with the inner side of the nasal cavity.
The filler body is of an integrated structure. The ratio of the filler body to the nasal cavity is 0.1-0.5: 1; after the liquid is absorbed, the ratio of the filler body to the nasal cavity is 1.2-1.5: 1.
The filler body is internally provided with a plurality of micropore structures. The micropore structure is internally provided with a medicament.
In the specific structure and size, the upper nasal meatus filling component 1, the middle nasal meatus filling component 2 and the lower nasal meatus filling component 3 are integrally formed, and all the components are matched with the actual structural shape of each nasal meatus, so that the nasal meatus is in an irregular three-dimensional shape;
as shown in fig. 4 and 5, when the nasal cavity filler is placed in the nasal cavity, the upper nasal passage filling assembly acts on the upper nasal passage of the nasal cavity; the upper meatus-filling member exhibits an irregular triangular-like shape with a longest length in the range of 25-50mm, preferably 35mm, and a highest height in the range of 7-12mm, preferably 9 mm.
The middle nasal passage filling component acts on the middle nasal passage of the nasal cavity; the middle nasal meatus filling component is in an irregular strip-like shape, the longest length ranges from 40 mm to 70mm, the preferential length ranges from 55mm, and the highest height ranges from 7 mm to 12mm, the preferential height ranges from 9 mm;
the lower nasal passage filling assembly acts on the lower nasal passage of the nasal cavity; the inferior meatus filling member exhibits an irregular concave-like elongated shape with a longest length in the range of 40-75mm, preferably 58mm, and a highest height in the range of 15-30mm, preferably 21 mm.
The diameter of the vent pipe is 3-5 mm.
Example 2
The following materials were mixed and foamed to prepare a filler.
Filling materials: polyvinyl alcohol: 80-99 percent; and (3) chitosan: 0 to 20 percent; alginate: 0 to 5 percent; gelatin: 0 to 10 percent;
the cross-linking agent is formaldehyde solution, the catalyst is concentrated hydrochloric acid, the stabilizing agent is sodium dodecyl sulfate, and the foaming agent is as follows: a water-soluble starch.
In this example, polyvinyl alcohol is used as a filler, and taking 15g of pva as an example, 15g of pva (polyvinyl alcohol) is taken as a raw material, 75mL of water is added, after stirring is carried out until the pva is completely dissolved, 15mL of formaldehyde solution (a cross-linking agent) and 2.5mL of concentrated hydrochloric acid (a catalyst) with the mass fraction of 30% are added, reaction is carried out for about 5 minutes, 2.5g of water-soluble starch (a foaming agent) and 1.5g of sodium dodecyl sulfate (a stabilizing agent) are added, and the reaction is carried out for 30 minutes at constant temperature, during which stirring is. Standing to room temperature after the foam is stable.
The preparation method of the nasal cavity filler comprises the following steps,
s1, acquiring CT or MRI scanning data in the nasal cavity, and establishing a three-dimensional model of the nasal cavity; in the step, the established three-dimensional model of the nasal cavity can be in equal proportion to the real nasal cavity 1:1, and can also be slightly larger or smaller than the real nasal cavity; preferably, the ratio of the three-dimensional model of the nasal cavity to the real nasal cavity is 0.9-1.1: 1.
S2, manufacturing a nasal cavity mold according to the three-dimensional nasal cavity model in a 3D printing mode; the volume of the cavity of the mold was 9.46ml by injecting water into the mold,
s3, filling 2g of the filling material subjected to foaming treatment into a nasal cavity mold, and drying and molding; the filling is microporous and has a density of about 0.21 g/ml.
S4, mechanically compressing the material formed in the step S3 to obtain the nasal cavity filler.
The volume of the compressed nasal cavity filler was about 0.98cm3. After being placed in water for 5s, the mixture expanded to the maximum volume of about 11.82cm3。
The above description is only exemplary of the present invention and should not be taken as limiting the scope of the present invention, as any modifications, equivalents, improvements and the like made within the spirit and principles of the present invention are intended to be included within the scope of the present invention.
Claims (7)
1. The nasal cavity filler is characterized by comprising a filler body,
the filler body is an elastic part which is reduced in proportion according to the shape of the nasal cavity;
the filler body is capable of absorbing liquid expansion;
after expansion, the filler body is an elastic piece which is enlarged in proportion to the shape of the nasal cavity.
2. The nasal cavity filler according to claim 1, wherein the filler body is provided with a plurality of ventilation passages;
when the filler body is placed in the nasal cavity, one end of the ventilation passage is communicated with the outer side of the nasal cavity, and the other end of the ventilation passage is communicated with the inner side of the nasal cavity.
3. The nasal cavity filling according to claim 1, wherein the filling body comprises at least one of an upper nasal passage filling assembly, a middle nasal passage filling assembly, a lower nasal passage filling assembly;
the upper nasal passage filling assembly is matched with the upper nasal passage of the nasal cavity; the middle nasal passage filling assembly is matched with the middle nasal passage of the nasal cavity; the inferior meatus filling component is matched with the inferior meatus of the nasal cavity.
4. The nasal cavity filler according to claim 1, wherein the filler body is a unitary structure.
5. The nasal cavity filling according to claim 1, wherein the ratio of the filling body to the nasal cavity is 0.1-0.5: 1; after the liquid is absorbed and expanded, the ratio of the filler body to the nasal cavity is 1.2-1.5: 1.
6. The nasal cavity filling according to any one of claims 1-5, wherein the filling body is provided with a plurality of micro-porous structures.
7. The nasal cavity filling according to claim 6, wherein the microporous structure is filled with a drug.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202022000813.4U CN212281498U (en) | 2020-09-14 | 2020-09-14 | Nasal cavity filler for hemostasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202022000813.4U CN212281498U (en) | 2020-09-14 | 2020-09-14 | Nasal cavity filler for hemostasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN212281498U true CN212281498U (en) | 2021-01-05 |
Family
ID=73934213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202022000813.4U Active CN212281498U (en) | 2020-09-14 | 2020-09-14 | Nasal cavity filler for hemostasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN212281498U (en) |
-
2020
- 2020-09-14 CN CN202022000813.4U patent/CN212281498U/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112022264A (en) | Nasal cavity filler for hemostasis and preparation method thereof | |
| CN212281498U (en) | Nasal cavity filler for hemostasis | |
| CN210494864U (en) | Disposable micro-noninvasive injection type cervical dilator | |
| CN202437233U (en) | Hemostatic device provided with air bag and used for front and rear nostrils of nasal cavity | |
| CN206587003U (en) | Obstetrics' hemostasis device | |
| CN110897671A (en) | Ventilated nasal cavity hemostatic device | |
| CN201691982U (en) | Ventilation type dual-purpose nasal cavity plugger | |
| CN215914795U (en) | Fish-bubble type nasal stent and medical appliance for prosthesis nose augmentation | |
| CN212729892U (en) | Nasal cavity hemostasis device | |
| CN206372089U (en) | Emergence fast hemostasis device | |
| CN2584137Y (en) | Nasal hemostatic embolus | |
| CN215839300U (en) | Ventilation expansion sponge plug for ear-nose-throat department | |
| CN221105921U (en) | Nasal cavity filler | |
| CN1053366A (en) | Hydrophilic polyurethane sponge dilator | |
| CN217285923U (en) | Liquid suction type nasal cavity compression hemostat | |
| CN215079145U (en) | Nasopharynx portion plugging device | |
| CN217592963U (en) | Hemostatic nasal plug | |
| CN221060754U (en) | Hemostatic device used after cervical conization | |
| CN215384332U (en) | Nasal cavity rapid hemostasis and ventilation device | |
| CN214970958U (en) | Uterine cavity expansion sacculus tube | |
| CN201564543U (en) | Vagina hemostat | |
| CN215018261U (en) | Uterine cavity compression balloon | |
| CN219331782U (en) | Nasal cavity hemostasis device | |
| CN215424889U (en) | Novel surgical nursing is with pressurization hemostasis device | |
| CN203789978U (en) | Nasal hemostatic sponge |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |